Schelling Pharma Private Limited - Company Profile

It is a trading private limited company based in Jaipur, Rajasthan, India, established in 2019.
2019 Jaipur, Rajasthan, India Active
Last Updated:
Access Report
About Schelling Pharma Private Limited

Schelling Pharma Private Limited, a active private limited company, was established on 19 March 2019 in Jaipur, Rajasthan, India. Engaging in specialty within the trading sector, it holds CIN: U51909RJ2019PTC064320. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Hem Lata Phoolia (Director), Ved Prakash Ahuja (Director), Naresh Kumar Anand (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 121, First Floor, City Plaza, Jhotwara Road, Jaipur, Rajasthan, 302016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909RJ2019PTC064320

  • Registration Number

    064320

  • Incorporation Date

    19 March 2019

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 6 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Schelling Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Schelling Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Schelling Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Hem Lata Phoolia Director 19 Mar 2019 Current
Ved Prakash Ahuja Director 19 Mar 2019 Current
Naresh Kumar Anand Director 19 Mar 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Schelling Pharma.

Schelling Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Schelling Pharma revenue growth over time
Schelling Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Schelling Pharma?

Unlock access to Schelling Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Schelling Pharma?

Unlock and access historical data on people associated with Schelling Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Schelling Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Schelling Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Schelling Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Schelling Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Schelling Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Jaipur. was documented.

  • Director Appointment

    Hem Lata Phoolia was appointed as a Director was appointed as a Director on 19 Mar 2019 & has been associated with this company since 6 years 11 months . was recorded as a recent event.

  • Director Appointment

    Ved Prakash Ahuja was appointed as a Director was appointed as a Director on 19 Mar 2019 & has been associated with this company since 6 years 11 months . was recorded as a recent event.

  • Director Appointment

    Progress on Naresh Kumar Anand was appointed as a Director was appointed as a Director on 19 Mar 2019 & has been associated with this company since 6 years 11 months . was documented.

  • Company Incorporation

    The activity Schelling Pharma Private Limited was registered on 19 Mar 2019 with Roc Jaipur & aged 6 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Schelling Pharma Private Limited?

The CIN of Schelling Pharma Private Limited is U51909RJ2019PTC064320.

Where is Schelling Pharma Private Limited headquartered?

Schelling Pharma Private Limited is headquartered at 121, First Floor, City Plaza, Jhotwara Road, Jaipur, Rajasthan, 302016.

When was Schelling Pharma Private Limited incorporated?

Schelling Pharma Private Limited was incorporated on 19 March 2019.

Who are the current directors of Schelling Pharma Private Limited?

The current directors of Schelling Pharma Private Limited are

What is the primary industry of Schelling Pharma Private Limited?

The primary industry of Schelling Pharma Private Limited is Trading.

Is Schelling Pharma Private Limited a listed company?

Schelling Pharma Private Limited is unlisted.

What is the capital structure of Schelling Pharma Private Limited?

The authorized capital of Schelling Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available